Viewing Study NCT04071405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-01-08 @ 3:52 PM
Study NCT ID: NCT04071405
Status: COMPLETED
Last Update Posted: 2024-09-03
First Post: 2019-08-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ulcerative colitis View
None Autoimmune Diseases View
None Immune System Diseases View
None Tofacitinib View
None Molecular Mechanisms of Pharmacological Action View
None Jak inhibitor View
None safety View